3-Chloro-4-isopropoxycyclobut-3-ene-1,2-dione

Catalog No. :
ACPSOA902
CAS No. :
130837-47-7
Molecular Formula :
C7H7ClO3
Molecular Weight :
174.58

IUPAC Name:3-chloro-4-isopropoxycyclobut-3-ene-1,2-dione

3-Chloro-4-isopropoxycyclobut-3-ene-1,2-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$99.00Login to see priceIn stockInquiry
5g95%$328.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-4-isopropoxycyclobut-3-ene-1,2-dione
IUPAC Name3-chloro-4-isopropoxycyclobut-3-ene-1,2-dione
MDL No.MFCD09763707
Molecular FormulaC7H7ClO3
Molecular Weight174.58
SMILESO=C1C(C(Cl)=C1OC(C)C)=O
InChI KeyFOAYRKHCUAPSBU-UHFFFAOYSA-N
Synonym130837-47-7 | 3-Chloro-4-isopropoxycyclobutene-1,2-dione | 3-chloro-4-isopropoxycyclobut-3-ene-1,2-dione | 3-chloro-4-propan-2-yloxycyclobut-3-ene-1,2-dione | MFCD09763707 | SCHEMBL9273688 | DTXSID80566139 | AMY32208 | AKOS006327362 | BS-20459 | SY281481 | CS-0444420 | FT-068541
CAS No.130837-47-7
PubChem CID14961824

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACPSOA902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPSOA902 route product structure diagram
    ACPSOA902130837-47-7 In Stock
Inquiry

2. ACPSOA902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPSOA902 route product structure diagram
    ACPSOA902130837-47-7 In Stock
Inquiry

Comments (0)